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LETTER TO THE EDITOR
Dear Sir,
We appreciate the detailed assessment of our
research conducted by Woodhead and colleagues,
but regret their interpretation that methodological
flaws in our study make our conclusions unsound.
We were at pains in our paper to emphasize the
need for caution when interpreting our findings,
but are concerned that readers of your correspon-
dents’ comments might not appreciate that the
long-term effect of declines in antibiotic prescrib-
ing for lower respiratory tract infection (LRTI) on
patient outcomes are far from clear.
The recent decline in the prescribing of anti-
biotics for LRTI is a potential cause for concern,
because there is little evidence investigating their
efficacy in routine clinical practice.1 Consequently,
the Standing Medical Advisory Committee on
Anti-Microbial Resistance focused its advice on
reducing antibiotic prescribing for uncomplicated
urinary tract and upper respiratory tract infections,
rather than LRTI.2 As noted by your correspondents,
existing studies of the effect of delayed antibiotic
prescribing on pneumonia outcomes have
been conducted in hospital,3,4 where chest radio-
graphy is routinely available for diagnostic
purposes. As pneumonia cannot be unambiguously
diagnosed in general practice, recent declines in
antibiotic prescribing (of up to 10.4% in the
over 65 age group, not 5.9% as stated by
your correspondents)5 are, therefore, of potential
concern.
Woodhead and colleagues cite two studies which,
they believe, refute our conclusions. The first
shows that a public and professional education
campaign reduced antibiotic prescribing for LRTI
without increasing consultations,6 and they inter-
pret this finding as demonstrating a lack of effect
on patient health. However, this study was not
powered to evaluate any effect on complications.
The second, conducted by one of your correspon-
dents, compares total antibiotic prescribing for
England with consultations for all acute respiratory
tract infections in England and Wales, from the
same group of sentinel practices as used in our
study.7 As in our study, this data was not amenable
to presentation by age group. However, whereas
our consultation and antibiotic prescribing data is
for LRTIs and restricted to a discrete winter period,
your correspondent’s study compares total annual
antibiotic prescribing with total annual consulta-
tions for acute respiratory tract infection through-
out the year. Furthermore, since publicity
highlighting the need to use antibiotics appropri-
ately has been aimed at the public as well as at
professionals, it is possible that changes in public
consultation patterns may have resulted, in rare
cases, in later presentation and more serious
illness. The evidence reviewed by Woodhead and
colleagues does not, therefore, address the central
question we raise.
Addressing additional points raised by the
authors, we chose pneumonia mortality as the
most clinically relevant endpoint, notwithstanding
the limitations of this type of data, which were
discussed in our paper. While errors may be made in
diagnosing pneumonia, these errors would have
needed to change systematically over our study
period before they could account for the associa-
tion we report, and there is no plausible reason or
evidence for this. Furthermore, while it is not
possible to separate hospital- from community-
acquired pneumonia in data derived from death
certificates, the vast majority of pneumonia deaths
occur from infections acquired in the community
rather than in hospital.
The incidence of respiratory infections is known
to peak in a predictable fashion each winter, and
our choice of winter period was based on published
data for England and Wales.8 When this winter
period was extended to 16 or 20 weeks (almost half
a year) in our sensitivity analyses, the observed
relationship between pneumonia mortality, influ-
enza incidence and antibiotic prescribing still held
(see Table 2 of our original publication). The
standardization of pneumonia mortality by influen-
za incidence queried by our respondents was for
illustrative purposes only (Fig. 1 of our publica-
tion); the logistic regression analysis on which our
conclusions are based was conducted using non-
standardized data and, therefore, age-standardiza-
tion was not required.
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Summer pneumonia mortality was remarkably
constant during our study period (Fig. 1 of our
publication) and, to avoid introducing extra varia-
bility, our calculation of excess winter pneumonia
mortality used a constant which remained un-
changed throughout the study. This constant
represented 85% of the lowest summer pneumonia
mortality during our 7-year study period, and not
85% of the mortality reported each summer, as
mistakenly reported by your correspondents. It
should be noted that the magnitude of this constant
affects only the trends graphed in Fig. 1 of our
paper, and not the observed statistical association
between winter pneumonia mortality, influenza
incidence and antibiotic prescribing.
We can confirm that the antibiotic prescribing
data included in our analysis was for England and
Wales only. We used Read codes, rather than ICD-10
codes as erroneously stated by your correspon-
dents, because these were included in the software
systems we accessed. Finally, it should be noted
that an incremental temporal variable was also
included in our sensitivity analyses, to take account
of concomitant secular changes, without affecting
the statistical association we observed (Table 2 of
our publication).
In view of the difficulties of identifying a
radiological consolidation in general practice, we
feel it imprudent to recommend that antibiotic
prescribing for LRTI can safely be reduced without
considering groups of patients most at risk of
pneumonia. The increase in winter pneumonia
mortality above incremental secular changes that
we have observed remains in need of explanation.
It is, therefore, important for clinicians to keep an
open mind on this topic, and we strongly agree with
Woodhead and colleagues that further research is
needed to support clinical decision-making in this
important area.
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